Hematologic Recovery and Deterioration After "Successful" Radiotherapy for Hodgkin's Disease

  1. RALPH E. JOHNSON, M.D.;
  2. LARRY E. KUN, M.D.;
  3. JOSEPH A. BELLADONNA, M.D.;
  4. SANDRA K. JOHNSON, R.N.;
  5. HARMAR D. BRERETON, M.D.; and
  6. GERALD A. COHEN, M.D.
  1. Bethesda, Maryland

    Abstract

    Long-term hematologic profiles have been compiled for 50 consecutive patients who remain continuously free of Hodgkin's disease, more than 5 years after nodal irradiation. Return of peripheral blood values to normal occurred consistently, and recovery has been sustained over the years of observation. In the entire series of 180 cases, only 7 patients have experienced a hematologic deterioration in the absence of further marrow suppressive therapy. Intervals from initial treatment to hematologic deterioration ranged from several weeks to more than 5 years. In three cases the cause could not be established before death. There was eventual histologic confirmation of recurrent Hodgkin's disease in six of the seven patients. Unexplained depression of peripheral blood counts after completion of radiotherapy should be interpreted as presumptive evidence for recurrent disease.

    Article and Author Information

    • ▸From the Radiation Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

    • ▸Reprint requests should be addressed to Ralph E. Johnson, M.D., Radiation Branch, National Cancer Institute, Bldg. 10, Room B3B38, National Institutes of Health, Bethesda, MD 20014.

    « Previous | Next Article »Table of Contents